For help on how to get the results you want, see our search tips.
45 results
Referral type
Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter
Articles 39 and 40 Remove Articles 39 and 40 filter
Article 29 paediatrics Remove Article 29 paediatrics filter
Article 13 Remove Article 13 filter
Article 78 Remove Article 78 filter
Medicine
Referrals Remove Referrals filter
-
List item
Referral: Seresto and its associated name Foresto
imidacloprid and flumethrin, associated names: Foresto, Article 13
Status: European Commission final decision, opinion/position date: 15/02/2018, EC decision date: 25/05/2018, Last updated: 10/07/2018 -
List item
Referral: Closamectin Pour-on Solution and associated names
Ivermectin, closantel, Article 78
Status: European Commission final decision, opinion/position date: 08/10/2015, EC decision date: 22/03/2016, Last updated: 31/05/2016 -
List item
Referral: Resflor solution injectable and associated names
florfenicol, flunixin, Article 13
Status: European Commission final decision, opinion/position date: 07/10/2014, EC decision date: 05/12/2014, Last updated: 09/01/2015 -
List item
Referral: Vasotop P
ramipril, Article 13
Status: European Commission final decision, opinion/position date: 08/12/2009, EC decision date: 27/04/2010, Last updated: 14/08/2014 -
List item
Referral: Cobactan DC and its associated names
cefquinome, associated names: Cephaguard DC, Cobactan DC intramam Susp. Ad us. Vet, Cobactan DC suspension intramammaire, Article 13
Status: European Commission final decision, opinion/position date: 20/07/2006, EC decision date: 13/10/2006, Last updated: 12/08/2014 -
List item
Referral: Bayovac IBR Marker Vivum
bovine Herpes Virus type 1 (BHV-1), strain Difivac (IBR-Marker Virus, gE-negative), modified live (attenuated) virus, associated names: Rhinobovin, Marker lebend, Rhinobovin Marker live, RhinobovinMarker Viva, Rhinobovin Marker Attenuato, Rhinobovin Marker Viva Marcada, Article 78
Status: European Commission final decision, opinion/position date: 21/01/2000, EC decision date: 10/07/2000, Last updated: 05/08/2014 -
List item
Referral: Crestor and associated names
rosuvastatin, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 30/06/2014, Last updated: 01/08/2014 -
List item
Referral: Cydectin TriclaMox
moxidectin / triclabendazole, Article 13
Status: European Commission final decision, opinion/position date: 16/07/2013, EC decision date: 25/09/2013, Last updated: 18/10/2013 -
List item
Referral: Soludox
doxycycline hyclate, Article 13
Status: European Commission final decision, opinion/position date: 12/06/2013, EC decision date: 12/08/2013, Last updated: 24/09/2013 -
List item
Referral: Ethinylestradiol-Drospirenone 24+4
ethinylestradiol / drospirenone, associated names: Yaz 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 06/07/2012, Last updated: 11/01/2013 -
List item
Referral: Yaz 24+4
ethinylestradiol / drospirenone, associated names: Ethinylestradiol-Drospirenone 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 03/07/2012, Last updated: 11/01/2013 -
List item
Referral: Valproat Ratiopharm Chrono
valproic acid / valproate, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 25/05/2010, EC decision date: 26/05/2010, Last updated: 23/07/2012 -
List item
Referral: Cozaar
irbesartan, associated names: Loortan, Loortan Cardio Start, Cozaar Startpakkle, Cardopal Start, Lorzaar, Lorzaar start, Lorzaar Protect, Pinzaar, Lorzaar Varipharmstart, Lortaan, Neo-Lotan, Losaprex, Cozaar IC, Lortaar IC, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 23/10/2008, EC decision date: 22/01/2009, Last updated: 13/01/2012 -
List item
Referral: Hiprabovis Pneumos
Mannheimia haemolytica biotype A serotype A1, inactivated cell free suspension containing leukotoxoid Ph. Eur. / inactivated Histophilus somni Bailie strain, Article 78
Status: European Commission final decision, opinion/position date: 14/07/2011, EC decision date: 03/11/2011, Last updated: 12/12/2011 -
List item
Referral: Sortis
atorvastatin, associated names: Lipitor, Zarator, Orbeos, Tahor, Liprimar, Atorvastatin, Atorvastatina, Edovin, Obradon, Xarator, Torvast, Totalip, Texzor, Cardyl, Prevencor, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 01/07/2010, Last updated: 27/04/2011 -
List item
Referral: Sortis
atorvastatin, associated names: Lipitor, Zarator, Orbeos, Tahor, Liprimar, Atorvastatin, Atorvastatina, Edovin, Obradon, Xarator, Torvast, Totalip, Texzor, Cardyl, Prevencor, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 01/07/2010, Last updated: 27/04/2011 -
List item
Referral: Sortis
atorvastatin, associated names: Lipitor, Zarator, Orbeos, Tahor, Liprimar, Atorvastatin, Atorvastatina, Edovin, Obradon, Xarator, Torvast, Totalip, Texzor, Cardyl, Prevencor, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 01/07/2010, Last updated: 27/04/2011 -
List item
Referral: Genotropin
somatropin, associated names: Genotonorm, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 02/09/2010, Last updated: 26/04/2011 -
List item
Referral: Xalatan
latanoprost, associated names: Latanoprost Pharmacia & Upjohn, Xalatan 50 mikrogramov/ml kaplijice za oko, raztopina, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 15/10/2010, Last updated: 08/12/2010 -
List item
Referral: Pregsure BVD
Inactivated Bovine Viral Diarrhoea (BVD) type 1 virus, cytopathogenic strain 5960, Article 78
Status: European Commission final decision, opinion/position date: 15/07/2010, EC decision date: 07/10/2010, Last updated: 22/10/2010 -
List item
Referral: Porcilis M Hyo
Inactivated whole cell concentrate of Mycoplasma hyopneumoniae strain 11, Articles 39 and 40
Status: European Commission final decision, opinion/position date: 19/05/2010, EC decision date: 16/08/2010, Last updated: 18/08/2010 -
List item
Referral: Porcilis PRRS
Live attenuated PRRS virus strain DV, Articles 39 and 40
Status: European Commission final decision, opinion/position date: 19/05/2010, EC decision date: 16/08/2010, Last updated: 18/08/2010 -
List item
Referral: Diovan
valsartan, associated names: Angiosan, Diovane, Tareg, Cordinate, Provas, Dalzad, Rixil, Kalpress Cardio, Diovan Cardio, Miten Cardio, Valsartan Novartis, Kalpress, Miten, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 15/12/2009, EC decision date: 19/04/2010, Last updated: 31/05/2010 -
List item
Referral: Diovan
valsartan, associated names: Angiosan, Diovane, Tareg, Cordinate, Provas, Dalzad, Rixil, Kalpress Cardio, Diovan Cardio, Miten Cardio, Valsartan Novartis, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 15/12/2009, EC decision date: 19/04/2010, Last updated: 31/05/2010 -
List item
Referral: Arimidex
anastrozole, Article 29 paediatrics
Status: European Commission final decision, EC decision date: 06/11/2009, Last updated: 28/05/2010